March 25, 2024
“…Over the past year, Chipotle stock has gained an impressive 74%, but that’s just the beginning. For those lucky enough to get in on its IPO in early 2006, the stock has soared from $22 to roughly $2,798, a mind-boggling… Continue Reading…
August 23, 2022
“…Best Buy, Ford Motor, HBO Max, Peloton, Shopify, Re/Max, Walmart and Wayfair are among the firms that announced layoffs in recent weeks. Meanwhile, 50% of firms are anticipating a reduction in overall headcount, while 52% foresee instituting a hiring freeze and 44% rescinding job offers, according to a PwC survey of… Continue Reading…
March 18, 2022
“About 50% of leaders say their company already requires or is planning to require employees to return to in-person work full-time in the next year, according to new research from Microsoft, which surveyed 31,102 workers around the world between January and… Continue Reading…
January 13, 2022
“The U.S. Army, for the first time, is offering a maximum enlistment bonus of $50,000 to highly skilled recruits who join for six years, The Associated Press has learned, as the service struggles to lure soldiers into certain critical jobs… Continue Reading…
September 11, 2020
“Houghton Mifflin (HMHC)… Based on all of the above, Warmington rates HMHC an Overweight along with a $5 price target. Should his thesis play out, a potential twelve-month gain of 121% could be in the cards… Gap (GPS)… It should… Continue Reading…
April 8, 2020
“We don’t know yet which companies are going to get how much in federal bailout money and what the bailout terms will be. But it’s a sure bet that a ton of money will be earmarked for our nation’s four… Continue Reading…
January 13, 2020
“Shares of Mastercard (NYSE:MA) gained 58.3% last year, according to data provided by S&P Global Market Intelligence. That compares to a return of 28.9% for the S&P 500 index. The payment processor continued to post stellar growth rates on the top and bottom line. Investors see… Continue Reading…
November 6, 2019
“SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications, today announced that it filed a certificate of amendment to… Continue Reading…
October 18, 2019
“China will at least double its spending on U.S. agriculture as part of a partial trade accord between the two countries that’s likely to be well received by crop traders when markets reopen. Under terms of the arrangement, spending will… Continue Reading…
Recent Comments